前列腺是临床上重要的男性性器官，其主要功能是制造精液。在全球范围内，它是男性第二常见的癌症，也是男性第五大癌症死亡原因。尽管对前列腺癌的了解有所改善，但目前使用血清前列腺特异性抗原（PSA）作为诊断标记仍不理想。
适应症：Prostate Cancer
入组条件
纳入标准
- Adult male patients with age \> 18 years old
- Subject has elevated serum PSA level above 4ng/ml
- Clinical planned for prostatic biopsy.
排除标准
- Patient with recent urinary tract infection within 6 weeks prior to PSA testing and urine collection.
- Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to PSA testing and urine collection.
- Patient with consumption of 5 alpha reductase inhibitors in past 6 months.
- Patient did not receive any surgery for prostatic pathology
- Patient refused or unable to provide consent for the study
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。